The Kennedy Trust for Rheumatology Research is a registered UK charity [1] which funds the Kennedy Institute as well as a range of individual UK university-based researchers. Its longer-term objective is to "achieve a meaningful impact in the development of cures and preventative treatment for musculoskeletal and related inflammatory diseases". [2]
In 1965, Mathilda Kennedy, daughter of Michael Marks and her husband Terence Kennedy, founded the Mathilda and Terence Kennedy Institute of Rheumatology. [3]
The Kennedys became interested in rheumatism after their general practitioner Dr Leslie Lankester was diagnosed with rheumatoid arthritis. [4]
The Kennedy Trust was registered as a charity in 1970. [5]
Mathilda and Terence Kennedy donated £500,000 to found the Kennedy Institute of Rheumatology in Hammersmith, the first institute in the world to be totally dedicated to the causes and cures of rheumatic diseases. [6]
The first director of the Kennedy Institute was Professor Dugald Gardner. [7] Succeeding directors included Dr Leonard Glynn, [8] Professor Helen Muir, [9] Professor Ravinder Maini, [10] Professor Marc Feldmann [11] and Professor Fiona Powrie. [12]
In 2000, the institute's staff and research activities were incorporated into Imperial College as a division of its newly formed Faculty of Medicine. [13]
In 2011, the Kennedy Institute became part of the University of Oxford as an independent constituent Institute within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science (NDORMS). [14] In 2013 the Institute moved into a new building co-funded by the Kennedy Trust and the University of Oxford. [15]
In the mid-1980s, discoveries made by teams led by Ravinder Maini and Marc Feldmann, led the way to anti-TNF therapy being used as a successful treatment for rheumatoid arthritis. [6]
The archives of the Kennedy Trust are held at Wellcome Collection (ref no: SA/KET).
This article incorporates
text available under the
CC BY 4.0 license.
The Kennedy Trust for Rheumatology Research is a registered UK charity [1] which funds the Kennedy Institute as well as a range of individual UK university-based researchers. Its longer-term objective is to "achieve a meaningful impact in the development of cures and preventative treatment for musculoskeletal and related inflammatory diseases". [2]
In 1965, Mathilda Kennedy, daughter of Michael Marks and her husband Terence Kennedy, founded the Mathilda and Terence Kennedy Institute of Rheumatology. [3]
The Kennedys became interested in rheumatism after their general practitioner Dr Leslie Lankester was diagnosed with rheumatoid arthritis. [4]
The Kennedy Trust was registered as a charity in 1970. [5]
Mathilda and Terence Kennedy donated £500,000 to found the Kennedy Institute of Rheumatology in Hammersmith, the first institute in the world to be totally dedicated to the causes and cures of rheumatic diseases. [6]
The first director of the Kennedy Institute was Professor Dugald Gardner. [7] Succeeding directors included Dr Leonard Glynn, [8] Professor Helen Muir, [9] Professor Ravinder Maini, [10] Professor Marc Feldmann [11] and Professor Fiona Powrie. [12]
In 2000, the institute's staff and research activities were incorporated into Imperial College as a division of its newly formed Faculty of Medicine. [13]
In 2011, the Kennedy Institute became part of the University of Oxford as an independent constituent Institute within the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science (NDORMS). [14] In 2013 the Institute moved into a new building co-funded by the Kennedy Trust and the University of Oxford. [15]
In the mid-1980s, discoveries made by teams led by Ravinder Maini and Marc Feldmann, led the way to anti-TNF therapy being used as a successful treatment for rheumatoid arthritis. [6]
The archives of the Kennedy Trust are held at Wellcome Collection (ref no: SA/KET).
This article incorporates
text available under the
CC BY 4.0 license.